China's fentanyl ban a 'game-changer' for opioid epidemic, DEA officials say
China will ban the manufacture and sale of four variations of the synthetic drug fentanyl starting March 1, a move that US Drug Enforcement Administration officials call a "game-changer" for the United States' battle with manufactured opioids.
DEA
spokesman Russ Baer confirmed that China made the announcement
Wednesday night, after six months of talks between the Chinese and US
governments. That included a January visit by acting DEA Administrator Chuck Rosenberg -- the first DEA administrator to go to China in more than a decade -- to to discuss the issue.
"It's been a great exchange, and this is great news. It's a potential game-changer," Baer said.
The ban will stop carfentanil,
furanyl fentanyl, acrylfentanyl and valeryl fentanyl from being legally
manufactured and sold in China, effective March 1. That could have a
big impact on illegal imports to the United States, as China is the main
supplier of fentanyl to the US.
"The significance of that cannot be underestimated as it relates to the impact in the US," Baer said.
In
October 2015, China banned more than 100 synthetic chemicals, including
some fentanyl products. But Baer says there's an ongoing battle between
legislation and clandestine labs; each time one substance is banned, a
new one pops up to replace it.
No comments
Post a Comment